FI924668A - Foerfarande foer framstaellning av vaesentligen ren melfalanhydroklorid - Google Patents

Foerfarande foer framstaellning av vaesentligen ren melfalanhydroklorid Download PDF

Info

Publication number
FI924668A
FI924668A FI924668A FI924668A FI924668A FI 924668 A FI924668 A FI 924668A FI 924668 A FI924668 A FI 924668A FI 924668 A FI924668 A FI 924668A FI 924668 A FI924668 A FI 924668A
Authority
FI
Finland
Prior art keywords
mammalshydrochlorides
framework
melphalan
hydrochloride
alkanol
Prior art date
Application number
FI924668A
Other languages
English (en)
Other versions
FI102275B1 (fi
FI102275B (fi
FI924668A0 (fi
Inventor
Stephen William Poole
Timothy Paul Stanley
Geoffrey Divall
Terence William Packham
Joseph Knight
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI924668A publication Critical patent/FI924668A/fi
Publication of FI924668A0 publication Critical patent/FI924668A0/fi
Application granted granted Critical
Publication of FI102275B1 publication Critical patent/FI102275B1/fi
Publication of FI102275B publication Critical patent/FI102275B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Catalysts (AREA)
FI924668A 1987-11-19 1992-10-15 Menetelmä oleellisesti puhtaan melfalaanihydrokloridin valmistamiseksi FI102275B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB878727157A GB8727157D0 (en) 1987-11-19 1987-11-19 Pharmaceutical formulations
GB8727157 1987-11-19
FI885358A FI90204C (fi) 1987-11-19 1988-11-18 Menetelmä injektoitavan melfalaanikoostumuksen valmistamiseksi
FI885358 1988-11-18

Publications (4)

Publication Number Publication Date
FI924668A true FI924668A (fi) 1992-10-15
FI924668A0 FI924668A0 (fi) 1992-10-15
FI102275B1 FI102275B1 (fi) 1998-11-13
FI102275B FI102275B (fi) 1998-11-13

Family

ID=10627252

Family Applications (2)

Application Number Title Priority Date Filing Date
FI885358A FI90204C (fi) 1987-11-19 1988-11-18 Menetelmä injektoitavan melfalaanikoostumuksen valmistamiseksi
FI924668A FI102275B (fi) 1987-11-19 1992-10-15 Menetelmä oleellisesti puhtaan melfalaanihydrokloridin valmistamiseksi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI885358A FI90204C (fi) 1987-11-19 1988-11-18 Menetelmä injektoitavan melfalaanikoostumuksen valmistamiseksi

Country Status (22)

Country Link
US (1) US4997651A (fi)
EP (1) EP0317281B1 (fi)
JP (1) JP2693191B2 (fi)
KR (1) KR970002607B1 (fi)
AT (1) ATE83922T1 (fi)
AU (1) AU619781B2 (fi)
CA (1) CA1341114C (fi)
DE (1) DE3877151T2 (fi)
DK (1) DK172794B1 (fi)
ES (1) ES2052745T3 (fi)
FI (2) FI90204C (fi)
GB (1) GB8727157D0 (fi)
GR (1) GR3007287T3 (fi)
HK (1) HK108994A (fi)
HU (3) HU206671B (fi)
IE (1) IE63996B1 (fi)
IL (1) IL88419A (fi)
LV (1) LV10179B (fi)
NZ (2) NZ227004A (fi)
PT (1) PT89028B (fi)
SG (1) SG73894G (fi)
ZA (1) ZA888674B (fi)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009150278A1 (es) * 2008-06-10 2009-12-17 Capital, Business Y Gestión De Finanzas, S.L. Una composición farmacéutica de melfalano

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695751A (en) * 1993-04-08 1997-12-09 Cornell Research Foundation, Inc. Enhancing delivery of large neutral amino acid drugs
US5407672A (en) * 1993-04-08 1995-04-18 Cornell Research Foundation, Inc. Enhancing the anti-tumor effect of melphalan with L-amino acid oxidase
US6020004A (en) * 1997-04-17 2000-02-01 Amgen Inc. Biodegradable microparticles for the sustained delivery of therapeutic drugs
US5980904A (en) * 1998-11-18 1999-11-09 Amway Corporation Skin whitening composition containing bearberry extract and a reducing agent
GB2386066A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
AU2003253681B2 (en) * 2002-06-24 2008-05-01 Research Development Foundation Treatment of human multiple myeloma by Curcumin
AU2004320907A1 (en) 2003-08-26 2006-04-13 Research Development Foundation Osteoclastogenesis inhibitors and uses thereof
US7872050B2 (en) * 2005-03-14 2011-01-18 Yaupon Therapeutics Inc. Stabilized compositions of volatile alkylating agents and methods of using thereof
US8501818B2 (en) 2005-03-14 2013-08-06 Ceptaris Therapeutics, Inc. Stabilized compositions of alkylating agents and methods of using same
LT3494960T (lt) 2008-03-27 2021-02-25 Helsinn Healthcare Sa Stabilizuotos alkilinimo agentų kompozicijos ir jų naudojimo būdai
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
CN102458114A (zh) * 2009-05-29 2012-05-16 锡德克斯药物公司 包含环糊精衍生物的可注射美法仑组合物及其制备和使用方法
AR077384A1 (es) * 2010-07-05 2011-08-24 Eriochem Sa Una formulacion farmaceutica inyectable de melfalano.
US8921596B2 (en) * 2010-11-04 2014-12-30 Emcure Pharmaceuticals, Ltd. Process for the preparation of melphalan hydrochloride
PL3656393T3 (pl) 2011-04-28 2023-01-16 Oncopeptides Ab Liofilizowany preparat cytotoksycznych dipeptydów
SI2928463T1 (sl) * 2012-10-26 2020-03-31 Oncopeptides Ab Liofilizirani pripravki melfalan flufenamida
US9963422B2 (en) 2013-03-11 2018-05-08 Biophore India Pharmaceuticals Pvt. Ltd. Process for the synthesis of melphalan and the hydrochloride salt
ITMI20130896A1 (it) * 2013-05-31 2014-12-01 Farmabios Spa Processo di purificazione di melphalan
US10576101B2 (en) * 2015-03-06 2020-03-03 Leadiant Biosciences Sa Roneparstat combined therapy of multiple myeloma
US10537520B2 (en) * 2015-06-30 2020-01-21 Leiutis Pharmaceuticals Pvt. Ltd. Stable liquid formulations of melphalan
ES2928931T3 (es) * 2018-03-29 2022-11-23 Project Pharmaceutics Gmbh Formulación farmacéutica líquida
US10682326B1 (en) 2019-06-03 2020-06-16 Shilpa Medicare Limited Stable melphalan liquid injectable formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB750155A (en) * 1953-03-17 1956-06-13 Nat Res Dev Substituted alanines
US3032585A (en) * 1954-12-03 1962-05-01 Nat Res Dev Process for the production of p-bis-(2-chloroethyl)-aminophenylalanine
DE1292660B (de) * 1963-04-24 1969-04-17 Ural Polytechnitscheskij I Im Verfahren zur Herstellung von p-(Bis-ª‰-chloraethyl-amino)-phenylalanin-hydrochlorid
US4029778A (en) * 1969-01-23 1977-06-14 Aktiebolaget Leo Cortical steroid nitrogen mustard compositions and treatment therewith
RO57195A2 (fi) * 1970-11-30 1974-09-01
FR2285855A1 (fr) * 1974-09-25 1976-04-23 Kohjin Co Composition therapeutique lyophilisee a base de sel de cyclocytidine et son procede de preparation
JPS59186924A (ja) * 1983-04-08 1984-10-23 Kureha Chem Ind Co Ltd ヒト免疫グロブリン結合抗腫瘍剤
US4696814A (en) * 1985-08-21 1987-09-29 Warner-Lambert Company Parenteral phenytoin compositions
JPS62192357A (ja) * 1986-02-19 1987-08-22 Kureha Chem Ind Co Ltd Ｎ−フタロイル−ｐ−ニトロ−Ｌ−フエニルアラニンの製造方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009150278A1 (es) * 2008-06-10 2009-12-17 Capital, Business Y Gestión De Finanzas, S.L. Una composición farmacéutica de melfalano

Also Published As

Publication number Publication date
US4997651A (en) 1991-03-05
NZ239867A (en) 1992-11-25
IE883447L (en) 1989-05-19
HUT48198A (en) 1989-05-29
GR3007287T3 (fi) 1993-07-30
DK646688A (da) 1989-05-20
IL88419A0 (en) 1989-06-30
HU203197B (en) 1991-06-28
DE3877151D1 (de) 1993-02-11
FI885358A0 (fi) 1988-11-18
SG73894G (en) 1994-11-25
FI90204C (fi) 1994-01-10
FI102275B1 (fi) 1998-11-13
EP0317281B1 (en) 1992-12-30
JP2693191B2 (ja) 1997-12-24
FI102275B (fi) 1998-11-13
KR970002607B1 (ko) 1997-03-06
IE63996B1 (en) 1995-06-28
EP0317281A2 (en) 1989-05-24
LV10179A (lv) 1994-10-20
EP0317281A3 (en) 1989-08-09
GB8727157D0 (en) 1987-12-23
HU9100335D0 (en) 1991-08-28
KR890007729A (ko) 1989-07-05
HU206671B (en) 1992-12-28
AU619781B2 (en) 1992-02-06
PT89028B (pt) 1993-02-26
PT89028A (pt) 1988-12-01
AU2574888A (en) 1989-05-25
NZ227004A (en) 1992-11-25
CA1341114C (en) 2000-10-10
HK108994A (en) 1994-10-14
JPH01153628A (ja) 1989-06-15
LV10179B (en) 1995-06-20
ATE83922T1 (de) 1993-01-15
ES2052745T3 (es) 1994-07-16
IL88419A (en) 1993-03-15
DK646688D0 (da) 1988-11-18
HU910336D0 (en) 1991-08-28
DK172794B1 (da) 1999-07-19
FI924668A0 (fi) 1992-10-15
ZA888674B (en) 1990-07-25
FI885358A (fi) 1989-05-20
FI90204B (fi) 1993-09-30
HU207286B (en) 1993-03-29
DE3877151T2 (de) 1993-07-15

Similar Documents

Publication Publication Date Title
FI924668A (fi) Foerfarande foer framstaellning av vaesentligen ren melfalanhydroklorid
MX166811B (es) Composicion refrigerante
HU905333D0 (en) Process for producing cyclic amino-acid derivatives
DE3169689D1 (en) Method of selectively increasing yield and purity of certain cryoprecipitate proteins
ATE241012T1 (de) Verfahren zur herstellung von humanen relaxin
PT77213A (de) Pasteurisiertes human-fibrinogen (hf) verfahren zu dessen herstellung und dessen verwendung
PL308742A1 (en) Method of recombining and host cell for producing xylythol
NO881746D0 (no) Fremgangsmaate for fremstilling av 17beta-(cyclopropylamino) androst-5-en-3beta-ol og beslektede forbindelser.
HUT45564A (en) Process for producing hirudine variants
ATE131490T1 (de) Verfahren zur herstellung von gereinigten albuminlösungen
FI891473A (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
DE3788921D1 (de) Verfahren zur Herstellung von 5-Methyltetrazol.
DK0473270T3 (da) Fremgangsmåde til fremstilling af et transparent, indstillet mælkevalleprotein og et indstillet mælkevalleproteinprodukt
ATE116636T1 (de) Verfahren zur herstellung von 2,6- dichlordiphenylaminessigsäurederivaten.
BR9205255A (pt) Aril aquil esteres de acido 4,5-dihidroxi-9,10-dihidro-9,10-dioxo-2-antraceno carboxilico com atividade terapeutica
ATE99662T1 (de) Verfahren zur herstellung von 1,1-dichlor-1fluorethan.
DE3063898D1 (en) Process for the preparation of substituted anthraquinones
NO933529D0 (no) Senkning av thromboksannivaa ved perkutan tilfoersel av aspirin
DE58902228D1 (de) Verfahren zur herstellung von 5-gliedrigen, stickstoffhaltigen heteroaromaten.
HUT47073A (en) Process for producing optically active amines
DK379387D0 (da) Optisk rene 1,3-dioxenoner, fremgangsmaade til fremstilling deraf og anvendelse heraf
BG34612A3 (en) Method for producing pyrolidine derivatives
ATE150438T1 (de) Verfahren zur herstellung von 1,1,1,2- tetrafluorethan
FI904912A0 (fi) Menetelmä (endo)-N- /(8-metyyli-8-atsabisyklo/3.2.1/oktan-3-yyli)amino/karbonyyli -2-(syklopropyylimetoksi)bentsamidin tai sen farmaseuttisesti hyväksyttävän happoadditiosuolan valmistamiseksi
ATE178051T1 (de) Verfahren zur herstellung einer physikalisch stabilen, kristallinen gamma-modifikation von para-aminobenzolsulfonamid

Legal Events

Date Code Title Description
MA Patent expired